Table of Contents Author Guidelines Submit a Manuscript
Pathology Research International
Volume 2012 (2012), Article ID 827815, 3 pages
http://dx.doi.org/10.1155/2012/827815
Review Article

Behcet's Disease and Endocrine System

Division of Endocrinology and Metabolism, Department of Internal Medicine, School of Medicine, Mersin University, 33079 Mersin, Turkey

Received 23 August 2011; Accepted 27 October 2011

Academic Editor: Ümit Tursen

Copyright © 2012 Onur Ozhan and Kerem Sezer. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. T. Sakane, M. Takeno, N. Suzuki, and G. Inaba, “Behcet's disease,” New England Journal of Medicine, vol. 341, no. 17, pp. 1284–1291, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  2. D. C. Aron, C. V. Finding, and J.B Thyrell, “Hypothalamus and pituitary gland,” in Basic and Clinical Endocrinology, F. S. Greenspan and D. G. Gardner, Eds., pp. 106–176, McGraw-Hill, New York, NY, USA, 7th edition, 2004. View at Google Scholar
  3. S. Akdeniz, S. Colak, A. K. Tuzcu, M. Bahceci, and M. Harman, “Baseline and stimulated thyroid functions in Behcet’s disease,” Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 7, pp. 878–879, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. K. Aksu, F. Oksel, G. Keser et al., “Thyroid functions in Behcet's disease,” Clinical Endocrinology, vol. 50, no. 3, pp. 406–407, 1999. View at Google Scholar
  5. K. Khiari, L. Cherif, I. Hadj Ali et al., “Central diabetes insipidus with Behcet disease. A case report,” Annales d'Endocrinologie, vol. 64, no. 6, pp. 426–427, 2003. View at Google Scholar
  6. A. Szymajda, M. S. Eledrisi, R. Patel, G. Chaljub, E. Cepeda, and P. Kaushik, “Diabetes insipidus as a consequence of neurologic involvement in Behcet’s syndrome,” Endocrine Practice, vol. 9, no. 1, pp. 33–35, 2003. View at Google Scholar · View at Scopus
  7. M. Jin-No, T. Fujii, Y. Jin-No, Y. Kamiya, M. Okada, and M. Kawaguchi, “Central Diabetes Insipidus with Behcet’s Disease,” Internal Medicine, vol. 38, no. 12, pp. 995–999, 1999. View at Google Scholar · View at Scopus
  8. F. Otsuka, T. Amano, T. Ogura, and Z. Ota, “Diabetes insipidus with Behcet's disease,” Lancet, vol. 346, no. 8988, pp. 1494–1495, 1995. View at Google Scholar · View at Scopus
  9. M. Hamza, S. Chamaki, and R. Boukris, “Diabetes insipidus in a case of Behcet’s disease with neurologic manifestations,” Presse Medicale, vol. 18, no. 35, p. 1755, 1989. View at Google Scholar · View at Scopus
  10. A. P. Çil, A. A. Karabulut, and M. Koçak, “Assessment of ovarian stromal artery Doppler characteristics and serum hormone levels in patients with Behçet disease,” Diagnostic and Interventional Radiology, vol. 16, no. 4, pp. 288–292, 2010. View at Publisher · View at Google Scholar · View at PubMed
  11. H. Proençha, C. Ferreira, M. Miranda, A. Castanheira-Dinis, and M. Monteiro-Grillo, “Serum prolactin levels and Behçet disease,” European Journal of Ophthalmology, vol. 17, no. 3, pp. 404–407, 2007. View at Google Scholar · View at Scopus
  12. M. Atasoy, S. Karatay, K. Yildirim, M. Kadi, T. Erdem, and K. Senel, “The relationship between serum prolactin levels and disease activity in patients with Behcet's disease,” Cell Biochemistry and Function, vol. 24, no. 4, pp. 353–356, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. H. Houman, I. Ben Ghorbel, M. Lamloum et al., “Prolactin levels in Behcet’s disease: no correlation with disease manifestations and activity,” Annales de Medecine Interne, vol. 152, no. 3, pp. 209–211, 2001. View at Google Scholar · View at Scopus
  14. P. M. Reber, “Prolactin and immunomodulation,” American Journal of Medicine, vol. 95, no. 6, pp. 637–644, 1993. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Neidhart, “Prolactin in autoimmune diseases,” Proceedings of the Society for Experimental Biology and Medicine, vol. 217, no. 4, pp. 408–419, 1998. View at Google Scholar · View at Scopus
  16. I. C. Chikanza, “Prolactin and neuroimmunomodulation: in vitro and in vivo observations,” Annals of the New York Academy of Sciences, vol. 876, pp. 119–130, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. L. J. Jara, C. Gomez-Sanchez, L. H. Silveira, P. Martinez-Osuna, F. B. Vasey, and L. R. Espinoza, “Hyperprolactinemia in systemic lupus erythematosus: association with disease activity,” American Journal of the Medical Sciences, vol. 303, no. 4, pp. 222–226, 1992. View at Google Scholar · View at Scopus
  18. R. Colak, Y. Ozkan, S. U. Cengiz, Y. Saral, B. C. Kandi, and I. Halifeoglu, “A comparison between the effects of low (1 μg) and standard dose (250 μg) ACTH stimulation tests on adrenal cortex functions with Behçet's disease,” Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 6, pp. 721–725, 2006. View at Publisher · View at Google Scholar · View at PubMed
  19. P. Sánchez Sobrino, C. P. Fernández, J. L.L. Ferreiro, B. M. Gil, R. P. Carballeira, and R. V. García-Mayor, “Behçet disease with isolated ACTH deficiency,” Endocrinologia y Nutricion, vol. 56, no. 9, pp. 463–466, 2009. View at Publisher · View at Google Scholar
  20. S. K. Kim, J. Y. Choe, S. H. Park, S. W. Lee, G. H. Lee, and W. T. Chung, “Increased insulin resistance and serum resistin in Korean patients with Behcet’s disease,” Archives of Medical Research, vol. 41, no. 4, pp. 269–274, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  21. H. Erdem, A. Dinc, S. Pay, I. Simsek, and M. Turan, “Peripheral insulin resitance in patients with Behçet’s disease,” Journal of the European Academy of Dermatology and Venereology, vol. 20, no. 4, pp. 391–395, 2006. View at Google Scholar